Reprint

Recent Advances in Pathophysiology and Therapeutic Approaches in Epilepsy

Edited by
October 2024
212 pages
  • ISBN978-3-7258-2182-2 (Hardback)
  • ISBN978-3-7258-2181-5 (PDF)
https://doi.org/10.3390/books978-3-7258-2181-5 (registering)

This is a Reprint of the Special Issue Recent Advances in Pathophysiology and Therapeutic Approaches in Epilepsy that was published in

Biology & Life Sciences
Computer Science & Mathematics
Medicine & Pharmacology
Public Health & Healthcare
Summary

Epilepsy is a widespread neurological disorder that affects around 70 million people worldwide. The main characteristic of this neurological disorder is the occurrence of unexpected and recurrent seizures. The cure for and management of epilepsy are confined to treating symptoms but do not modify the development and progression of the disease. Furthermore, among the people who are taking antiseizure medicines, more than 30% of them still have epilepsy, and long-term use of these drugs can result in a variety of side effects. Hence, there is an urgent need to understand the detailed pathophysiology and mechanism of the development of diverse forms of epilepsy as well as identify crucial therapeutic targets. Moreover, finetuning as well as examining the effectiveness of several surgical procedures and neuromodulation methods to treat drug-resistant epilepsy are also required.This Special Issue features original research and review articles by experts discussing the recent developments in the pathophysiology, risk factors and possible treatment options in diverse forms of epilepsy.

Format
  • Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
drug-resistant epilepsy; children; resection surgery; palliative surgery; seizure outcome; epilepsy; seizures; inflammation; anti-inflammatory response; flavonoids; epilepsy; seizures; dehydroepiandrosterone; neuronal loss; astroglial activation; dendritic degeneration; epilepsy; oxidative stress; mitochondrial dysfunction; inflammation; antioxidants; antiepileptic drugs; antiseizure medications; neuromodulation; keto diet; nutrients; drug-resistant epilepsy; hemispherotomy; surgical procedure; daytime-restricted feeding; oxidative stress; status epilepticus; Nrf2; SOD2; hippocampus; super-refractory status epilepticus; neuromodulation; electroconvulsive therapy; deep brain stimulation; vagus nerve stimulation; children epilepsy; IED and cognition; visuo-spatial skills; EEG score; transition readiness; epilepsy; psychological; parents; epilepsy; network; resection; ablation; neuromodulation; invasive monitoring; sEEG; epileptic syndromes; neurotransmission; comorbidities; clinical trials; animal epilepsy models; interictal spiking; therapeutic epileptiform activities; n/a